Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification.

Adams SD, Barracchini KC, Chen D, Robbins F, Wang L, Larsen P, Luhm R, Stroncek DF.

J Transl Med. 2004 Sep 13;2(1):30.

2.

High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA Analyzer.

Adams SD, Barracchini KC, Simonis TB, Stroncek D, Marincola FM.

Tumori. 2001 Mar-Apr;87(2):S40-3.

PMID:
11401225
3.

High-resolution HLA-A*0201 subtyping using directed heteroduplex analysis.

Kicklighter EJ, Lee KH, Barracchini KC, Bettinotti M, Norris R, Simonis TB, Stroncek D, Marincola FM.

J Immunother. 1999 May;22(3):219-28.

PMID:
10335481
4.

HLA antigens in childhood onset schizophrenia.

Jacobsen LK, Mittleman BB, Kumra S, Lenane MC, Barracchini KC, Adams S, Simonis T, Lee PR, Long RT, Sharp W, Sidransky E, Ginns EI, Rapoport JL.

Psychiatry Res. 1998 May 8;78(3):123-32.

PMID:
9657416
5.

Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.

Cormier JN, Salgaller ML, Prevette T, Barracchini KC, Rivoltini L, Restifo NP, Rosenberg SA, Marincola FM.

Cancer J Sci Am. 1997 Jan-Feb;3(1):37-44.

6.

Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.

Dadmarz RD, Ordoubadi A, Mixon A, Thompson CO, Barracchini KC, Hijazi YM, Steller MA, Rosenberg SA, Schwartzentruber DJ.

Cancer J Sci Am. 1996 Sep-Oct;2(5):263-72.

PMID:
9166543
7.

Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocols.

Player MA, Barracchini KC, Simonis TB, Rivoltini L, Arienti F, Castelli C, Mazzocchi A, Belli F, Parmiani G, Marincola FM.

J Immunother Emphasis Tumor Immunol. 1996 Sep;19(5):357-63.

PMID:
8941875
8.

Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.

Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA, et al.

Cancer Res. 1995 Jul 15;55(14):3149-57.

Supplemental Content

Loading ...
Support Center